☆ 4.7 Editorial Material

Hunting for Progressive NAFLD in Type 2 Diabetes: Do Not Trust Liver Enzymes!

DIABETES CARE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Mary E. Rinella et al.

HEPATOLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

Zobair M. Younossi et al.

Summary: A comprehensive meta-analysis was conducted to assess the global and regional prevalence, incidence, and mortality of non-alcoholic fatty liver disease (NAFLD). The results showed that the global prevalence of NAFLD is 30% and increasing, highlighting the need for urgent and comprehensive strategies to raise awareness and address NAFLD on local, regional, and global levels.

HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes

Veeral Ajmera et al.

Summary: This study evaluated the prevalence of advanced fibrosis and cirrhosis in patients with T2DM, and found that the prevalence of fibrosis was 14% and cirrhosis was 6%. These results highlight the high risk of advanced fibrosis/cirrhosis in T2DM patients aged >-50 years.

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Article Endocrinology & Metabolism

High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold

Laurent Castera et al.

Summary: This study assessed the yield of using routinely available data to identify patients with type 2 diabetes (T2DM) and nonalcoholic steatohepatitis (NASH) or advanced fibrosis (AF). The results showed that routinely available data could accurately predict the occurrence of AF and NASH, and had significant value in identifying patients requiring further liver assessment.

DIABETES CARE (2023)

添加到收藏夹

Article Endocrinology & Metabolism

Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023

Nuha A. ElSayed et al.

DIABETES CARE (2023)

添加到收藏夹

Review Medicine, General & Internal

The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

Tom H. Karlsen et al.

LANCET (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

Elisabetta Bugianesi et al.

Summary: NAFLD, a common liver disease associated with obesity and diabetes, has been extensively studied by researchers to provide practical recommendations on epidemiology, diagnosis, and treatment.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)

添加到收藏夹

Article Endocrinology & Metabolism

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)

Kenneth Cusi et al.

Summary: This article provides evidence-based recommendations for the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) for endocrinologists, primary care clinicians, and other stakeholders. The guideline includes 34 evidence-based clinical practice recommendations and contains relevant citations.

ENDOCRINE PRACTICE (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Annalisa Berzigotti et al.

Summary: The article provides the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for assessing liver disease severity and prognosis, with a focus on topics with relevant evidence published in the last 5 years.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis

Yoosoo Chang et al.

HEPATOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

Ankur Srivastava et al.

JOURNAL OF HEPATOLOGY (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

Zobair M. Younossi et al.

JOURNAL OF HEPATOLOGY (2019)

添加到收藏夹

Editorial Material Endocrinology & Metabolism

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects

Hermann Toplak et al.

DIABETOLOGIA (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Giulio Marchesini et al.

JOURNAL OF HEPATOLOGY (2016)

添加到收藏夹

Letter Medicine, General & Internal

Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels

Brent A. Neuschwander-Tetri et al.

ARCHIVES OF INTERNAL MEDICINE (2008)

添加到收藏夹

Article Medicine, General & Internal

Updated definitions of healthy ranges for serum alanine aminotransferase levels

D Prati et al.

ANNALS OF INTERNAL MEDICINE (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.